Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-18.17	34.30	41.92
Graham Fair Price	19.80	20.70	17.27
PEG	-88.67	0.59	5.23
Price/Book	-20.08	5.11	6.39
Price/Cash Flow	46.21	49.51	33.86
Prices/Earnings	-29.38	15.72	22.26
Price/Sales	-16.38	4.37	5.23
Price/FCF	46.21	49.51	33.86
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	15.72	0.18	0.16
Operating Margin	14.39	0.11	0.10
ROA	23.84	0.02	0.02
ROE	0.07	0.08	13.17
ROIC	0.03	0.04	24.12
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	0.03	-57.07
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.13	0.23	75.86
EPS QOQ	0.04	0.27	523.47
FCF QOQ	0.44	-0.38	-12.80
Revenue QOQ	-0.05	0.08	39.04
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-99.90
Days Sales Outstanding (DSO)	89.57	85.83	-4.18
Inventory Turnover	186389.00	194673000.00	104344.47
Debt/Capitalization	0.64	0.59	-8.12
Quick Ratio	2.04	2.32	13.59
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.60	15.31	12.61
Cash	9.26	10.21	10.25
Capex	-0.16	-0.11	28.75
Free Cash Flow	2.56	1.58	-38.45
Revenue	16.62	17.89	7.62
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.10	2.39	13.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	6.53	5.37	-17.65
Naive Interpretation	Member

06 - Financial Health · Bad

Rating